Differential effects of TFG-β and FGF-2 on  in vitro  proliferation and migration of primate retinal endothelial and Müller cells by Romo, Phillip et al.
Introduction
A distinguishing feature of the pri-
mate retina is the specialized macula
lutea, which includes the fovea cen-
tralis. The fovea is a shallow depres-
sion in the central retina adapted for
high acuity vision. Foveal adapta-
tions include an absence of retinal
vessels and rod photoreceptors and
centrifugal displacement of inner reti-
nal layers onto the foveal rim (Pro-
vis & Hendrickson 2008). Factors
that induce specialization of the mac-
ula and formation of the fovea
remain poorly understood. However,
establishment of the foveal avascular
zone (FAZ) is a likely key step in
delineation of the fovea during devel-
opment (Provis & Hendrickson
2008). This notion is supported by
clinical investigations using optical
coherence tomography showing that
when the FAZ is absent, the foveal
depression is also absent (McGuire
et al. 2003).
Vascularization of the retina
involves proliferation and migration
of astrocytes and endothelial cells, so
that the vessels spread outward from
the disc and reach the peripheral
retina at around birth. Retinal vessels
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ABSTRACT.
Purpose: During retinal development, the pattern of blood vessel formation
depends upon the combined effects of proliferation and migration of endothe-
lial cells, astrocytes and Müller cells. In this study, we investigated the poten-
tial for transforming growth factor-b (TGF-b) and fibroblast growth factor
(FGF-2) to influence this process by regulating proliferation and migration of
retinal endothelial and macroglial cells.
Methods: We assessed the effects of exogenous TGF-b and FGF-2 on the pro-
liferation and migration of cultured endothelial (RF ⁄6A) and Müller cell
(MIO-M1) lines. Cell proliferation was measured using a MTT [3-(4,5-dim-
ethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) colorimetric assay over
72 hr. Cell migration was measured using a scratch-wound assay over 72 hr.
Results: Transforming growth factor-b inhibited the proliferation of endothe-
lial and Müller cells and inhibited the migration of Müller cells, but not endo-
thelial cells, compared to untreated controls. Conversely, FGF-2 increased
endothelial cell proliferation but inhibited endothelial cell migration. Fibroblast
growth factor-2 increased migration of Müller cells but had little effect on
proliferation except at higher concentrations (20 ng ⁄ml).
Conclusion: Taken together, these observations indicate that TGF-b and FGF
could work in concert to inhibit endothelial cell proliferation and migration,
respectively; this may have implications for establishing and maintaining the
avascular zone of primate fovea.
Key words: endothelial cells – fibroblast growth factor – foveal avascular zone – Müller cells –
primate retina – transforming growth factor-b
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and their associated astrocytes enter
the retina from the optic disc at about
14 weeks’ gestation (WG) in humans
(Provis & Hendrickson 2008). How-
ever, the foveal region is never vascu-
larized during normal development,
and the FAZ is fully demarcated by
around 28 WG in humans (Provis &
Hendrickson 2008). Astrocytes leading
the endothelial cell migration into the
retina express vascular endothelial
growth factor (VEGF) in response to
local hypoxia (Sandercoe et al. 2003).
Despite the high levels of VEGF
expression throughout the developing
macula, vessels growing towards the
macula advance more slowly than in
other parts of the retina (Engerman
1976; Provis et al. 2000). A lower rate
of cell proliferation is found in vessels
approaching the macula compared to
vessels growing towards the periphery
in primate fetal retina (Cornish et al.
2005). These observations lead to the
hypothesis that expression of a gradi-
ent of antiangiogenic or antiprolifera-
tive factors such as transforming
growth factor-b (TGF-b) or fibroblast
growth factor-2 (FGF-2), centred on
the incipient fovea, may explain the
delayed vascularization of the central
retina and establishment of the FAZ.
Transforming growth factor-b is stro-
ngly expressed in the retina (Anderson
et al. 1995) and has previously been
shown to inhibit the proliferation of
astrocytes (Hunter et al. 1993). In this
study, we used in vitro primate endo-
thelial and Müller cell models to
further investigate the potential for
TGF-b and FGF-2 to regulate
cell proliferation and migration.
Materials and Methods
Endothelial and Müller cell cultures
Cell lines
A rhesus macaque choroid-retina
endothelial cell line (RF ⁄ 6A, CRL-
1780, American Type Culture Collec-
tion) and an immortalized human
Müller cell line, MIO-M1 [Müller 1
Moorefields Institute of Ophthalmo-
logy; Dr A. Limb, Institute of Ophthal-
mology, University College London
(Limb et al. 2002)] were used. Cells
were grown in Dulbecco’s modified
Eagle medium (DMEM), supple-
mented with 10% heat-inactivated
fetal bovine serum (FBS), 50 units ⁄ml
penicillin and 50 units ⁄ml streptomy-
cin and 2mm l-glutamine and main-
tained in a humidified incubator at
37C with 5% CO2. The medium
was changed every 3 days, and cells
were passaged using 0.25% trypsin ⁄
0.1% ethylenediaminetetraacetic acid
(EDTA) in phosphate-buffered saline
(PBS) when cells were approximately
80% confluent. All tissue culture
reagents were obtained from Thermo-
Trace Pty Ltd (Australia) unless
otherwise specified.
We initially confirmed that MIO-
M1 Müller and RF ⁄ 6A endothelial
cell lines expressed receptors for TGF-
b and FGF-2, required for cells to
respond to the growth factors used in
the proliferation and migration assays
(not shown).
Proliferation assays
We measured the dose response of
TGF-b and FGF-2 on cell prolifera-
tion for both cell lines. Endothelial
and Müller cells were seeded at
2 · 104 cell ⁄ml in 96-well plates and
grown for 24 hr in DMEM growth
medium, followed by 24 hr in
serum-free medium (SFM). Cells were
treated with TGF-b or FGF-2 at
concentrations of 4, 8, 12, 16 or
20 ng ⁄ml in SFM (N = 6 wells ⁄ con-
centration). Control cells grown in
SFM only were also included (N =
6 wells). The experiment was repeated
on three separate occasions (N = 18
wells total). For the proliferation
assay, cells were grown for 72 hr
then 10 ll of MTT reagent was
added to each well and incubated in
the dark at 37C for 4 hr, with
100 ll of solubilization reagent added
to the wells overnight to dissolve the
formazan crystals. Absorbance was
measured at 570 nm with a 650-nm
reference (BioRad Microplate Reader,
Model 550, Bio-Rad Laboratories,
Hercules, CA, USA). Absorbances
for untreated control cells were aver-
aged for each separate experiment
(Cavg). For each growth factor
concentration tested, e.g. 2 ng ⁄ml,
the absorbance (D) was expressed
as a percentage of Cavg; that is,
(D ⁄Cavg) · 100% = % Cavg Dose–
response curves were then plotted for
each cell line (% Cavg ± SEM,
N = 18 for control and each growth
factor concentration).
Cell migration assays
We measured the effect of TGF-b and
FGF-2 on the migration of Müller and
endothelial cell lines using a scratch-
wound assay. Cells were seeded in 12-
well plates (Müller cells 1 · 105
cells ⁄ml; endothelial cells 7.5 · 104
cells ⁄ml) and grown for 48 hr to 85%
confluence in DMEM, followed a
24-hr adaptation in SFM. Cell prolifer-
ation was blocked with 10 lg ⁄ml mito-
mycin-C for 2 hr. Uniform wounds
were then made in confluent cell mono-
layers using a 1-ml pipette tip drawn
vertically across the centre of the well;
all wounds were made by an indepen-
dent investigator (MCM). This tech-
nique produced a consistent wound
devoid of cells, 5 mm long · 600 lm
wide. Wells were then gently washed
twice with PBS to remove any cell
debris, and the wounds were assessed
for consistency.
Cells were treated with either TGF-
b (10 ng ⁄ml), FGF-2 (10 ng ⁄ml) or,
for controls, SFM. The growth factor
concentration used was determined
empirically from dose–response assays.
For each experiment, four wells per
treatment group were assessed (N = 4
per growth factor). Digital images of
wound areas were captured using a
4· objective on a phase-contrast
light microscope Olympus IX71 with
a DP70 camera (Olympus, Tokyo,
Japan) and DP Controller v1.2.1.107
software (16 bits ⁄ channel, 1024 ·
1024 pixels), and wound areas were
viewed at T = 0, 6, 12, 24 and
48 hr postscratch. The experiment was
repeated twice on separate occasions,
giving a total of N = 8 wells for analy-
sis for each condition. At the comple-
tion of all experiments, wound areas
were analysed using the FoveaPro
Plug-in (Reindeer Graphics) for Adobe
PhotoshopCS2. The wound edge was
traced by hand, and the software was
used to select and calculate the area of
the wound. The area is calculated by
determining the number of pixels
within the traced area and scaling to
actual dimensions.
The order of growth factor admin-
istration, cell type and wounding
within the 12-well plates was random-
ized for each experiment to minimize
bias. All wound preparations were
maintained under identical conditions
before analysis. The distinct morpho-
logy of each cell type made masking
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of all experimental conditions unfeasi-
ble. To ensure consistency of measure-
ments and reduce bias, a separate
investigator (MCM) produced the
scratch-wounds with the same sized
pipette tip; however, the precise size of
the measured wound varied (reported
in results). All images were collected
and analysed by one investigator (PR),
and the same wound location was
imaged at each time-point, for each
experimental condition. Record of the
initial wound size and analysis of the
final wound size were unknown to
the investigator tracing the area until
objective calculation of pixel dimen-
sions by the software.
Statistical analysis
Wound areas were calculated as per
cent coverage compared to the initial
wound area (T = 0) to account for
any variation between initial wound
areas. Nonlinear regression analysis
was performed in sigmaplot v9.0
(Systat Software, Chicago, IL, USA)
for all values at respective time-points.
The rate of migration was modelled
against an increase to maximum,
2-parameter curve, and the equation
of curve was determined. Statistical
differences in the response to TGF-b
and FGF-2 were determined by poly-
nomial curve fitting:
Critical values of the F distribution
were taken as F(critical) [a(1); p =
0.01; df = 36] = 7.31.
Results
Fibroblast growth factor-2-treated
endothelial cells showed a dose-related
increase in proliferation to 116%
of controls (2–20 ng ⁄ml FGF-2;
Fig. 1A). For most concentrations of
FGF-2 (2–16 ng ⁄ml), Müller cell
proliferation did not differ from
untreated cells; however at 20 ng ⁄ml,
cell growth was reduced to 90% of
control levels (Fig. 1A). Transforming
growth factor-b (2 ng ⁄ml) significantly
decreased proliferation relative to
medium alone, for both endothelial
(85%) and Müller cells (87%)
(Fig. 1B).
Cell migration in vitro was mea-
sured using a scratch-wound assay,
with different patterns of wound heal-
ing observed for each cell type and
growth factor (Fig. 2). During endo-
thelial cell migration, the cells at the
wound front lost their characteristic
‘cobblestone’ arrangement and appea-
red to extend filopodia into the
wound area. Transforming growth
factor-b -treated Müller cells extended
long thin processes into the wound
area, while cell somata remained at
the wound front. In contrast, FGF-2-
treated Müller cells displayed rapid
migration into the wound area. These
migrating cells extended multiple
short thickened cell processes, and
individual cells were observed within
the wound area. In contrast to the
TGF-b -treated cells, the cell bodies
did not remain at the wound front
(Fig. 2).
Endothelial cells and Müller cells
displayed distinct cell migration rates
over 48 hr, in response to TGF-b and
FGF-2 (Table 1). In control SFM,
endothelial and Müller cells showed
different migration rates. Endothelial
cell migration was significantly more
rapid compared to Müller cells, and
at 48 hr, there was 45% and 55%
wound area coverage for Müller and
endothelial cells, respectively (p <
0.01) (Fig. 3). Müller cell migration
was significantly inhibited by TGF-b
(10 ng ⁄ml) to almost half the migra-
tion of controls (p < 0.01) (Fig. 3).
In contrast, FGF-2 (10 ng ⁄ml) signifi-
cantly promoted Müller cell migration
consistently across all time-points
(p < 0.01), reaching 100% wound
coverage by 48 hr. The response of
endothelial cells to TGF-b and FGF-2
was very different compared to Müller
cells. Endothelial cells in TGF-b
showed a similar migration pattern to
(A)
(B)
Fig. 1. Cell proliferation in vitro. (A) transforming growth factor-b treatment decreased endo-
thelial and Müller cell proliferation at doses from 2 to 20 ng ⁄ml (B) fibroblast growth factor
(FGF-2) treatment increased endothelial cell proliferation at all doses. Conversely, Müller cell
proliferation remained unchanged with 2–16 ng ⁄ml; a 10% decrease in proliferation from con-
trol levels is seen with 20 ng ⁄ml FGF-2.
F ¼ðregression of SS for highermodelÞ  ðregression SS for lower degreemodelÞ
residualMS for highermodel
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controls (p < 0.01), with a slight
increase in migration at 48 hr. In con-
trast, endothelial cells grown in FGF-
2 demonstrated a significant inhibition
of migration over 48 hr, achieving
only 36% wound coverage compared
to 55% coverage in controls
(p < 0.01) (Fig. 3).
Discussion
In this study, TGF-b inhibited the
proliferation of endothelial and Mül-
ler cells and inhibited the migration
of Müller cells, but not endothe-
lial cells, compared to untreated
controls. Conversely, FGF-2
increased endothelial cell proliferation
but inhibited endothelial cell migra-
tion and increased migration of Mül-
ler cells but showed minimal effects
on Müller cell proliferation except at
higher concentrations (20 ng ⁄ml).
These findings suggest that the com-
bined effects of TGF-b and FGF-2
could contribute to the differential
growth responses of endothelial cells
and Müller cells observed during nor-
mal retinal development and in
pathology.
Demarcation of the incipient fovea
is a perplexing issue. At no time
during development is the incipient or
developing fovea vascularized (Provis
& Hendrickson 2008). As vessels
approach the incipient fovea, their
rate of growth decreases, and endo-
thelial cell proliferation is decreased in
the vicinity of the incipient fovea and
along the horizontal meridian, com-
pared to the rest of the retina (Sander-
coe et al. 2003). It has been suggested
that antiproliferative and ⁄or anti-
angiogenic factor(s) are differentially
expressed along the horizontal merid-
ian and concentrated at the incipient
fovea. As well as controlling prolifera-
tion, these factors could limit migra-
tion of key cell types to produce a
complex morphological pattern consis-
tent with that observed during foveal
development. Consequently, the pres-
ence of such factor(s) would play an
important role in preventing vessel
growth into the central fovea (Provis
2001). The expression of such factor ⁄ s
would need to occur prior to any
physical marking of the FAZ by the
vasculature and associated cell types.
Indeed, it has been reported recently
that the antiangiogenic factors, PEDF
and brain natriuretic peptide, along
with the guidance factor EphA6, are
highly expressed in the developing
foveal region (Kozulin et al. 2009a,b).
Several growth factors including
VEGF, TGF-b and FGF-2 are invo-
lved in the highly complex and well-
controlled processes of primate retinal
vascular development (Sandercoe
et al.2003; Cornish et al. 2005). Con-
sistent with these observations, our in
vitro study shows that both TGF-b
and FGF-2 can inhibit endothelial cell
proliferation and migration, respec-
tively, suggesting the interaction of
these growth factors may play an
important role in maintaining an
avascular incipient fovea during pri-
mate retinal development.
The role of FGF-2 in eye develop-
ment has primarily related to its role
in lens development, where FGF-2 is
critical in regulating the differentiation
of lens epithelial cells to elongated
fibre cells in a dose-dependent manner
-reviewed in (Lovicu & McAvoy
2005). A definitive role for FGF-2 in
retinal vascular growth has not yet
been established. A normal retinal
vasculature was found to develop in
FGF-2 knockout mice; however, this
most likely is because of a redundancy
in growth factors and receptors
Fig. 2. Cell migration assays. Wound areas at T = 48 hr (blue outline) compared to areas at
T = 0 (red outline) for Müller and endothelial cells. These representative images show the dif-
ferent patterns of cell migration for each cell type.
Table 1. Nonlinear regression analysis of migration rates.
Migration rate comparison F F(critical) p value
Control Müller versus control endothelium 10.89 7.31 p<0.01*
Endothelium TGF-b versus control 6.75 7.31 p>0.01
Endothelium FGF-2 versus control 17.77 7.31 p<0.01*
Müller cell TGF-b versus control 22.77 7.31 p<0.01*
Müller FGF-2 versus control 22.82 7.31 p<0.01*
Comparison of migration rates in transforming growth factor-b (TGF-b) and fibroblast growth
factor (FGF)-2 treated and control (untreated) Müller and endothelial cells. Significant differ-
ences in migration rates occurred for all comparisons except for TGF-b -treated endothelial
cells. N = 38; F(critical): [a(1); p = 0.01; df = 36] = 7.31. * Significant differences between
the two conditions; p < 0.01.
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(Ozaki et al. 1998). In vitro studies
have suggested that FGF-2 stimulates
the expression of VEGF by endothe-
lial cells (Pepper & Mandriota 1998).
Fibroblast growth factor-2 has also
been reported to play a major role in
the development of cones in the foveal
region in primate retina, with the
establishment of an FGF-2 mRNA
gradient leading to localized elonga-
tion and thinning of foveal cones
(Cornish et al. 2005). In the current
study, we showed that FGF-2 has a
differential effect on the proliferation
and migration of Müller cells and
endothelial cells. Fibroblast growth
factor-2 increased endothelial cell pro-
liferation with no effect on Müller cell
proliferation. In contrast, FGF-2 pro-
moted migration of Müller cells but
inhibited endothelial cell migration.
This finding is significant, as it shows
that a complex pattern of advance-
ment, expansion and suppression of
growth of two key retinal cell types
can potentially be affected by combi-
nations of growth factors that display
gradients of expression in the develop-
ing primate retina.
Transforming growth factor-b is
implicated in regulating the differenti-
ation, proliferation, migration and
survival of many cell types. The three
isoforms: TGF-b1, TGF-b2, TGF-b3
overlap in their respective functions
(Lebrin et al. 2005). Transforming
growth factor-b2 can act on either of
two transmembrane serine ⁄ threonine
kinase receptors, TbR-II and two
TbR-I, one of which is restricted to
the endothelium (Lebrin et al. 2005).
In vitro, TGF-b can either increase
or decrease endothelial cell prolifera-
tion, dependent on the concentration,
where low doses of TGF-b stimulate
and high doses inhibit endothelial cell
proliferation (Goumans et al. 2002).
This balance is thought to be regu-
lated by ALK5 (which leads to the
inhibition of migration and prolifera-
tion) and ALK1 (which induces
migration and proliferation) signalling
(Goumans et al. 2002). Abnormalities
arising from gene knock-out of TGF-
b receptors and ligands (Larsson et al.
2001; Dickson et al. 1995) have dem-
onstrated the significant role that
TGF-b signalling plays in vascular
development. Transforming growth
factor-b has been shown to indirectly
inhibit endothelial cell proliferation
and the expression of VEGF receptor
II in these cells (Lebrin et al. 2005).
Developmentally, Müller cells, pho-
toreceptors and a subset of inner reti-
nal neurons descend from a single
retinal progenitor cell (Turner & Cepko
1987). Müller cells are derived from the
end-stage differentiation of these pro-
genitor cells (Furukawa et al. 2000)
and provide a template for vascular
growth and patterning (Holländer
et al. 1991). In the developing retina,
Müller cells are involved in the phago-
cytosis of apoptotic neurons or pig-
ment epithelial cells (Egensperger et al.
1996). In the mature retina, Müller cells
play an important role in stabilizing the
architecture of the retina by providing
structural support for both vasculature
and neuronal components (Zhang &
Stone 1997). The promotion of Müller
cell process extension and migration by
FGF-2 and TGF-b observed here has
implications for the Müller cell hyper-
trophy and invasion commonly seen in
retinal diseases, including age-related
macular degeneration.
We have demonstrated that TGF-b
can inhibit the proliferation of endo-
thelial cells and Müller cells. In
response to hypoxia, Müller cells
release TGF-b that can inhibit prolif-
eration of retinal neurons and Müller
cells, in a paracrine and autocrine
fashion, respectively (Yafai et al.
2004). Transforming growth factor-b,
along with other cytokines, has been
implicated along with other cytokines
in the regulation of matrix metallo-
proteinases, which play a crucial role
in normal physiological, developmen-
tal and pathological processes of
angiogenesis and wound healing in the
eye (Eichler et al. 2002). In this study,
the rate of Müller cell proliferation
decreased with TGF-b, similar to the
response observed for endothelial
cells. Taken together, the present
observations suggest that TGF-b and
FGF-2 may be involved in defining
the FAZ by differential regulation of
(A)
(B)
Fig. 3. Migration of (A) Müller cells and (B) endothelial cells. For Müller cells, a significant
increase in migration is induced by transforming growth factor-b (TGF-b) (10 ng ⁄ml) compared
to control serum-free medium (p < 0.01) and a significant decrease is seen with fibroblast
growth factor (FGF-2) (10 ng ⁄ml) (p < 0.01). For endothelial cells, the migration rates are
similar for TGF-b-treated and control (serum-free) cells, compared to a significant decrease in
migration induced by FGF-2 (p < 0.01).
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endothelial and Müller cell prolifera-
tion and migration.
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